Physician profile
Daniel James Smeester
NPI 1306872841
$691.53
in general payments reported to CMS, 2019-2025
12 companies · $307 in 2025
The $307 reported for 2025 was more than what 75% of Addiction Medicine (Preventive Medicine) providers received nationally (typical 2025 total: $115).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $87.23 · 2022: $36.37 · 2024: $20.92 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $327.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $196.46 | 2025 | Ha Minuteman G3-R |
| Orexo US, INC. | $146.23 | 2019 | |
| Braeburn INC. | $110.52 | 2025 | Brixadi |
| Siemens Medical Solutions USA, INC. | $60.49 | 2020 | |
| Spr Therapeutics, INC | $34.87 | 2019 | |
| Medtronic USA, INC. | $33.96 | 2019-2020 | |
| Avanos Medical | $23.83 | 2019 | |
| Abbott Laboratories | $20.92 | 2024 | Proclaim |
| Stimwave Technologies Incorporated | $19.44 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $16.93 | 2022 | |
| Biodelivery Sciences International, INC. | $15.25 | 2020 | |
| Mdd US Operations, LLC | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Smeester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.